Psychedelics in End-of-Life Care

This chapter examines the potential of psilocybin and other psychedelics in alleviating existential distress for patients facing terminal illnesses. It highlights historical and cultural uses of these substances along with modern therapeutic perspectives, including discussions on microdosing and the importance of scientific validation. The chapter warns of the risks associated with both microdosing and higher therapeutic doses, emphasizing the need for careful research and structured medical approaches.